• Processa Pharmaceuticals appointed Sheila Gujrathi executive chair of its board, with responsibility for supporting corporate strategy, capital allocation and organizational development.
• Gujrathi founded Vidya Therapeutics and served as its executive chair before Processa acquired it in June 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Processa Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610290800PRIMZONEFULLFEED9855826) on October 29, 2026, and is solely responsible for the information contained therein.